Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Telomir Pharmaceuticals, Inc. Common Stock
Market Cap
$82.53M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.47M
EBITDA Margin
-8103.88%
TTM Avg
-7583.93%
3Y Avg
-8667.05%
5Y Avg
-7944.60%
Market Cap
$82.59M
EBITDA Margin
-63075.78%
TTM Avg
-211942.49%
3Y Avg
-892870.62%
5Y Avg
-626625.43%
Market Cap
$81.22M
EBITDA Margin
-3237.56%
TTM Avg
-3237.56%
3Y Avg
-2112.78%
5Y Avg
-1492.65%
Market Cap
$81.20M
EBITDA Margin
-398.90%
TTM Avg
-349.10%
3Y Avg
-274.94%
5Y Avg
-268.47%
Market Cap
$84.13M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.30M
EBITDA Margin
-4911.29%
TTM Avg
-4911.29%
3Y Avg
-4895.51%
5Y Avg
-4835.22%
Market Cap
$79.61M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $82.53M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -8103.88% | -7583.93% | -8667.05% | -7944.60% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | -63075.78% | -211942.49% | -892870.62% | -626625.43% |
| LENSAR Inc (LNSR)vs › | $82.29M | -34.36% | -23.48% | -28.76% | -37.09% |
| MediciNova, Inc. (MNOV)vs › | $81.22M | -3237.56% | -3237.56% | -2112.78% | -1492.65% |
| Nutriband Inc. (NTRB)vs › | $81.20M | -398.90% | -349.10% | -274.94% | -268.47% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -4911.29% | -4911.29% | -4895.51% | -4835.22% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | N/A | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
